WASHINGTON, DC—Newly reported data from the TRILUMINATE randomized trial provide more objective evidence in support of transcatheter edge-to-edge repair (TEER) in patients with symptomatic severe ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback